Freenome

Freenome is a biotechnology company that develops blood-based tests for early cancer detection. It combines multiomics (cell-free DNA and protein signals) with machine learning. Its mission is to detect cancer earlier and change how it is managed. Its lead program is a blood-based colorectal cancer screening test, which is being commercialized in partnership with Exact Sciences.